Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis by Melean, German et al.
CASE REPORT Open Access
Monozygotic twins with Neurofibromatosis type
1, concordant phenotype and synchronous
development of MPNST and metastasis
German Melean
1, Alba Marina Hernández
1, María Carmen Valero
1,2, Elisabete Hernández-Imaz
1, Yolanda Martín
1,
Concepción Hernández-Chico
1*
Abstract
Background: Neurofibromatosis type 1 is a common autosomal dominant disorder with full penetrance and
variable expression. The condition predisposes individuals to the development of malignant nervous system
tumours, most frequently Malignant Peripheral Nerve Sheath Tumours (MPNSTs). Previous studies indicate that
genetic factors other than mutations in NF1 may be responsible for the condition’s variable expression.
Case report: Here we present data from a pair of monozygotic twins affected by Neurofibromatosis type 1
resulting from a de novo mutation. Both twins developed a left sciatic plexiform neurofibroma that evolved into
MPNST at a similar age and they also developed pulmonary metastasis at the same age. Other concordant traits
between the twins were: macrocephaly, psychomotor delay, café-au-lait spots, cutaneous neurofibromas,
retroperitoneal, pleural and paraspinal neurofibromas. The main discordant features observed were tibial
pseudoarthrosis, pectus carinatum, osteoporosis and thymus hyperplasia.
Conclusions: This is the first report of monozygotic twins with Neurofibromatosis type 1 that develop MPNSTs, the
localization and chronological evolution of which, and its metastasis, is concordant in both twins. These cases
suggest that the events involved in the transformation of benign plexiform neurofibromas to MPNSTs in
Neurofibromatosis type 1, follow a spatiotemporally programme that is influenced by heritable factors other than
NF1 mutations.
Background
Neurofibromatosis type 1 (NF1, MIM #162200) is a
common autosomal dominant disorder that affects
about 1 in 3,500 individuals worldwide, predisposing
individuals to develop tumours in the nervous system.
The condition is caused by mutations in the NF1 gene
located at 17q11.2 that encodes neurofibromin, a 2,818
amino acid GTPase activating protein (GAP) which reg-
ulates p21-ras proto-oncogene activity [1]. About half of
the NF1 cases represent de novo mutations.
NF1 is a fully penetrant condition although its presen-
tation is variable. The main defining features are
multiple “café au lait” spots (CLS), skin fold freckling,
Lisch nodules and cutaneous neurofibromas [2]. Plexi-
form neurofibromas (PNFs) and optic gliomas are also
common neoplastic manifestations associated with NF1.
In NF1 patients, between 10-15% of the PNFs transform
into Malignant Peripheral Nerve Sheath Tumours
(MPNSTs) [3], which in turn metastasize in an early
phase and are associated with a poor prognosis [4].
Other features associated with the condition are learning
disabilities, macrocephaly, scoliosis, pseudoarthrosis and
epilepsy.
Although many different mutations have been reported
in NF1 [5], no genotype-phenotype relationships have
been found, except for large deletions encompassing the
entire NF1 gene and its flanking chromosomal regions
(NF1 microdeletions), or a 3 bp deletion in exon 17 of
NF1 (c.2970-2972delAAT; p.990delM). NF1 microdele-
tions are associated with the appearance of a large number
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any medium, provided the original work is properly cited.of cutaneous neurofibromas, dysmorphic features, learning
disabilities and an elevated risk of MPNSTs [6,7]. By con-
trast, the small deletion in exon 17 is associated with a
milder phenotype and the absence of neurofibromas [8].
A contribution of modifying genes not linked to the
NF1 locus might explain the variable expression of this
condition. This hypothesis is supported by phenotype
correlation studies in different groups of affected rela-
tives, including monozygotic (MZ) twins [9,10], and
through the analysis of intrafamilial associations
between the clinical features of NF1 [11,12].
Better understanding of MPNST variable occurrence
in NF1 has been elusive, due to the tumor’sl o wf r e -
quency and the uncommon presentation in multiple
members of the same family. Here we report an illustra-
tive case of NF1 MZ twins with PNF in similar anatomi-
cal location that transformed to MPNST and produced
pulmonary metastasis, simultaneously in both twins.
Case Report
Two 27 year-old male MZ twins were referred to our
Unit for molecular analysis of the NF1 gene. The pro-
bands were born after an uncomplicated pregnancy to
healthy non-consanguineous unaffected parents, with no
prior family history of NF1. The twins have an unaf-
fected brother 4-years older who suffered mild psycho-
motor delay and dysphasia in early childhood. The twins
grew to adulthood and they are currently still living
together.
Both twins presented with minimal cutaneous mani-
festations, including approximately 15 CLS and a few
cutaneous neurofibromas (detailed clinical data is
reported in Table 1). A relevant tumour phenotype was
observed in both twins. In “Twin 1”,M R Ip e r f o r m e da t
20 years of age detected one PNF of the left sciatic
popliteal nerve and many small neurofibromas in both
legs surrounding the femoropopliteous vessels. Although
the PNF was resected due to the distal pain in the leg,
at 22 years of age a further surgical intervention was
performed to resect a tumour detected by MRI in the
same region. Pathological analysis of the resected tissue
diagnosed a MPNST of the sciatic popliteal nerve and a
PNF. Although the patient was subjected to a cycle of
radiotherapy after surgery, the MPNST recurred twice 2
and 4 years later. These tumours were treated surgically,
leading to the amputation of the left leg in the last
operation. In “Twin 2”, MRI examination at 20 years of
age identified bilateral PNFs of the sciatic nerves and at
24 years of age, the tumour in the left leg was surgically
resected due to its rapid growth and malignant radiolo-
gical aspect. The pathological analysis of the resected
tissue diagnosed high grade MPNST of the left sciatic
nerve and hence, a cycle of radiotherapy was adminis-
tered after surgery.
A pulmonary metastatic MPNST was detected in both
twins at 27 years of age. “Twin 1” developed the metas-
tasis in the lower lobule of the right lung, while “Twin
2” presented the metastasis in the upper lobe of the left
lung. The concordant and discordant manifestations
associated with NF1 in these twins are presented in
Table 1.
Mutational NF1 analysis and twins’ zygosity test
Lymphocyte RNA was obtained from fresh peripheral
blood and RT-PCR was performed to amplify overlap-
ping cDNA fragments that covered the entire gene. The
PCR products were analyzed by Denaturing High Per-
formance Liquid Chromatography (DHPLC) and the
positive fragments in the DHPLC analysis were
sequenced. The mutations found were confirmed by
direct sequencing of the genomic DNA and in this way,
the c.4537 C®T mutation (Arg1513X) was found in
exon 27a of the NF1 gene from both twins. The muta-
tion was not present in the twins’ parents or brother.
Twins’ zygosity was confirmed by analysing 14 poly-
morphic microsatellite markers at different chromoso-
mal loci. Informed consent for genetic analysis was
obtained from all family members included in this study.
Case Discussion
We report here a pair of NF1 MZ twins with remark-
able concordance in their tumour phenotype. The
c.4537 C®T disease-causing mutation was found in
both twins and it is a nonsense mutation that has been
recurrently found in subjects with NF1 [13], although it
does not appear to be associated with any particular
clinical feature of the disease.
Macrocephaly, CLS and cutaneous neurofibromas are
concordant traits in our twins, as was reported pre-
viously in a cohort of six MZ twin pairs [9]. Concor-
dance among more distant relatives was weaker,
indicating that genetic factors other than the mutant
NF1 allele influence the expression of these traits [9-11].
Psychomotor delay and learning disabilities develop in
30-60% of individuals affected by NF1, and learning dis-
abilities were seen to be 100% concordant in NF1 MZ
twins [9,10]. In this sense, our probands presented simi-
lar alterations, although both responded well to therapy.
However, it is not possible to confirm that this feature
is associated with NF1 as the twins’ older unaffected
brother also displayed learning problems during early
childhood and responded well to therapy.
Scoliosis and tibial dysplasia were only evident in
“Twin 1”, consistent with the low correlation coefficient
of 0.17 established in 6 MZ twins [10], even though sco-
liosis was previously reported to be a concordant feature
in another 3/3 NF1 MZ twins [9]. There is no prior
information on tibial dysplasia in MZ twins with NF1
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associated with parathyroid gland disease [14].
PNFs were previously found to have a strong concor-
dance among NF1 MZ twins, yet while concordance was
lower in more distant relatives, loci other than NF1 were
thought to modulate this feature [9,10]. Our observa-
tions are in accordance with such an influence.
To our knowledge, this is the first report of NF1 MZ
t w i n sw i t hM P N S T sa n dw h a ti sm o r e ,b o t ht w i n s
developed MPNSTs at similar ages and at the same scia-
tic PNF location. Indeed, pulmonary metastases also
appeared simultaneously in both twins at 27 years of
age. Significantly, “Twin 2” developed another PNF in
the right sciatic nerve that is still under surveillance.
Our current understanding of the molecular mechan-
isms underlying PNF transformation into a MPNST is
still limited. Two events seem to be essential for the
development of NF1 tumours: the inactivation of the
remaining wild type NF1 allele (somatic mutation) in a
schwann cell precursor; and a tumour microenviron-
ment produced by the NF1 haploinsufficency in other
tumoural elements (fibroblasts, perineural-like fibro-
blasts and mast cells). This microenvironment provides
crucial mitogenic signals to homozygous mutated NF1
schwann cells [15]. In addition to the double mutation
of the NF1 gene, additional genetic alterations also seem
to be required to permit the transformation of benign
PNF into MPNST. These alterations include inactivation
of cell-cycle associated genes such as TP53, RB1 and
CDKN2A which encodes p16(INK4A) and p14(ARF)
[16,17]. However, a recent study reported LOH of TP53
and RB1 in a minority of cutaneous neurofibromas (4.5
and 1.1% respectively) [16]. Gene expression profiling in
NF1-associated benign and malignant tumours identified
relatively widespread deregulation of genes in developing
schawnn cells and in particular, the SOX9 gene seems to
Table 1 Clinical features of “Twin 1” and “Twin 2”
Age at diagnosis FEATURE TWIN 1 TWIN 2
At birth CLS ++
Macrocephaly + +
Pectus carinatum + -
Scoliosis + -
Tibial pseudoarthrosis + -
Childhood Mild psychomotor delay + +
Developmental dysphasia + +
Hyperkinesia/attention disorder + +
Hypotonia - +
Strabismus - +
Dental development delay + -
Right valgus foot + +
Bilateral flat feet + +
Normal cranial CT + +
Normal ophthalmologic examination + +
14 Y/O Radial intraneural neurofibroma + -
20 Y/O Plexiform neurofibroma of the left sciatic nerve + +
(bilateral)
Multiple neurofibromas surrounding femoropopliteous vessels + -
22 - 24 Y/O MPNST of the left sciatic nerve + (22 Y/O) + (24 Y/O)
24-27 Y/O MPNST recurrences + -
Osteoporosis - +
Thymus hyperplasia - +
Bilateral gynecomastia - +
Left lung focal pleural thickening + +
Pleural neurofibroma + (multiple) + (one)
Hepatic hypodense lesion + +
Paraspinal plexiform neurofibroma - +
Psoas plexiform neurofibroma + -
Multiple retroperitoneal neurofibromas + +
27 Y/O Pulmonary MPNST metastasis + (right lung) + (left lung)
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instability (MSI) has also been associated with peripheral
nerve NF1 tumours, both benign and malignant [16,19]
Malignant tumours present higher levels of MSI than
benign ones and these findings suggest that mismatch
repair genes (MMR) may also participate in the malig-
nant transformation of NF1-associated tumours [20,21].
Unfortunately, we could not perform further molecular
investigations in our twins since no further tumour tis-
sue was available.
The most exceptional feature in our twins is that con-
cordance was not only detected in terms of the presence
of a MPNST in both twins but also, in the location and
chronological evolution. An interesting theory has been
proposed that may be related with this concordance,
based on the assumption that the potential for angio-
genesis varies spatiotemporally in different vascular
fields. Hence, it was suggested that NF1 deficiency may
disrupt some vascular fields, producing anatomical
regions that are prone to develop tumours and malfor-
mations [22].
Previous reports in MZ twins with BRCA1 and BRCA2
mutations suggest that an analogous regulated program
may also occur in other kinds of hereditary tumours.
Similar to this case, in MZ twins with mutations in
BRCA1 and BRCA2 tumours were detected at the same
approximate location and same age [23,24].
Conclusions
For the first time, we report NF1 MZ twins concordant
for MPNSTs, with a similar clinical presentation of scia-
tic nerve PNF, as well as a similar malignant and meta-
static evolution. This case indicates that the events
needed for the transformation of a PNF to MPNST, and
their subsequent metastasis, follow a chronological and
spatially regulated programme, where heritable factors
other than the NF1 mutation exert a strong influence.
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